Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop*

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474

Tau is a candidate gene for chromosome 17 frontotemporal dementia

Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374

Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B., Geschwind, D., Bird, T., McKeel, D., Goate, A., et al. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,024

Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy

Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781

Tau protein pathology in neurodegenerative diseases

Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683

Structure and novel exons of the human .tau. gene

Andreadis, A., Brown, W. M., & Kosik, K. S. (1992) · Biochemistry · doi:10.1021/bi00158a027 · Cited by 659

Corticodentatonigral Degeneration With Neuronal Achromasia

Rebeiz, J. J., Kolodny, E. H., & Richardson, E. P. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00470310034003 · Cited by 627

A novel X‐linked four‐repeat tauopathy with Parkinsonism and spasticity

Poorkaj, P., Raskind, W. H., Leverenz, J. B., Matsushita, M. M., Zabetian, C. P., Samii, A., Kim, S., Gazi, N., Nutt, J. G., Wolff, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23085 · Cited by 27

Clinicopathological features of the tauopathies

Murray, B., Lynch, T., & Farrell, M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330595 · Cited by 27

Corticobasal syndrome: a practical guide

Wilson, D., Le Heron, C., & Anderson, T. (2021) · Practical Neurology · doi:10.1136/practneurol-2020-002835 · Cited by 25

Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes

Vasilevskaya, A., Taghdiri, F., Burke, C., Tarazi, A., Naeimi, S. A., Khodadadi, M., Goswami, R., Sato, C., Grinberg, M., Moreno, D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102212 · Cited by 27

Association of the Tau haplotype with Parkinson's disease in the Greek population

Fidani, L., Kalinderi, K., Bostantjopoulou, S., Clarimón, J., Goulas, A., Katsarou, Z., Hardy, J., & Kotsis, A. (2006) · Movement Disorders · doi:10.1002/mds.20864 · Cited by 26

New Genes, New Dilemmas: FTLD Genetics and Its Implications for Families

Goldman, J. S., Adamson, J. L., Karydas, A., Miller, B. L., & Hutton, M. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507306662 · Cited by 27

MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

Valentino, R. R., Scotton, W. J., Roemer, S. F., Lashley, T., Heckman, M. G., Shoai, M., Martínez-Carrasco, A., Tamvaka, N., Walton, R. L., Baker, M., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00083-8 · Cited by 25

Preliminary Evidence that VEGF Genetic Variability Confers Susceptibility to Frontotemporal Lobar Degeneration

Borroni, B., Ghezzi, S., Agosti, C., Archetti, S., Fenoglio, C., Galimberti, D., Scarpini, E. A., Luca, M. D., Bresolin, N., Comi, G. P., et al. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0711 · Cited by 25

Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies

Badiola, N., Suárez‐Calvet, M., & Lleó, A. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793237403 · Cited by 26

Neuropathological validation of the MDS-PSP criteria with PSP and other frontotemporal lobar degenerationPreprint

Gazzina, S., Respondek, G., Compta, Y., Allinson, K. S. J., Spillantini, M. G., Molina‐Porcel, L., Guasp, M., Moftakhar, S., Reich, S. G., Hall, D. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/520510 · Cited by 24

Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates

Ling, H., Gelpí, E., Davey, K., Jaunmuktane, Z., Mok, K. Y., Jabbari, E., Simone, R., R’Bibo, L., Brandner, S., Ellis, M. J., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02119-4 · Cited by 24

MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features

Valentino, R. R., Koga, S., Walton, R. L., Soto‐Beasley, A. I., Kouri, N., Deture, M. A., Murray, M. E., Johnson, P. W., Petersen, R. C., Boeve, B. F., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01097-z · Cited by 23

Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils

Li, J., Kumar, A., Långström, B., Nordberg, A. K., & Ågren, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00437 · Cited by 25

Biomarkers in the primary progressive aphasias

Grossman, M. (2014) · Aphasiology · doi:10.1080/02687038.2014.929631 · Cited by 25

RNA Interference: A Potential Therapeutic Tool for Silencing Splice Isoforms Linked to Human Diseases

Gaur, R. K. (2006) · BioTechniques · doi:10.2144/000112165 · Cited by 23

Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population

Pepłońska, B., Żekanowski, C., Religa, D., Czyźewski, K., Styczyńska, M., Pfeffer, A., Gabryelewicz, T., Gołębiowski, M., Łuczywek, E., Wasiak, B., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00788-2 · Cited by 23

Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism regionPreprint

Bekpen, C., Tastekin, I., Siswara, P., Akdiş, C. A., & Eichler, E. E. (2012) · Genome Research · doi:10.1101/gr.134098.111 · Cited by 23

Age-Dependent Association between the Q7R Polymorphism in the Saitohin Gene and Sporadic Alzheimer’s Disease

Combarros, O., Rodero, L., Infante, J., Palacio, E., Llorca, J., Fernández‐Viadero, C., Peña, N., & Berciano, J. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000071000 · Cited by 22

Cognitive dysfunction in corticobasal degeneration

de Oliveira, L. M., Barcellos, I., Teive, H. A. G., & Munhoz, R. P. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170077 · Cited by 26

Progressive supranuclear palsy: clinical and genetic aspects

Pástor, P., & TOLOSA, E. S. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00005 · Cited by 22

Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

Manzoni, C., Kia, D. A., Ferrari, R., Leonenko, G., Costa, B., Saba, V., Jabbari, E., Tan, M. M. X., Albani, D., Álvarez, V., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.05.017 · Cited by 24

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue

Tauber, C. V. I., Schwarz, S. C., Rösler, T. W., Arzberger, T., Gentleman, S., Windl, O., Krumbiegel, M., Reis, A., Ruf, V., Herms, J. W., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01534-9 · Cited by 21

Progressive supranuclear palsy

Burn, D. J., & Lees, A. J. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)84047-4 · Cited by 21

Argyrophilic grain disease: molecular genetic difference to other four-repeat tauopathies

Miserez, A. R., Clavaguera, F., Monsch, A. U., Probst, A., & Tolnay, M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0742-x · Cited by 21

Tau neurotoxicity without the lesions: a fly challenges a tangled web

de Silva, R., & Farrer, M. J. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02170-7 · Cited by 21

The Relationship between Lewy Body Disease, Parkinson's Disease, and Alzheimer's Disease

Hardy, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07474.x · Cited by 21

Progress in Clinical Neurosciences: Frontotemporal Dementia-Pick's Disease

Kertesz, A. (2006) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100004893 · Cited by 20

Physiological Transgene Regulation and Functional Complementation of a Neurological Disease Gene Deficiency in Neurons

Peruzzi, P. P., Lawler, S. E., Senior, S. L., Dmitrieva, N., Edser, P. A. H., Gianni, D., Chiocca, E. A., & Wade‐Martins, R. (2009) · Molecular Therapy · doi:10.1038/mt.2009.64 · Cited by 20

Novel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives

Przewodowska, D., Marzec, W. Z., & Madetko‐Alster, N. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.720220 · Cited by 20

Anatamopathological spectrum of tauopathies

Révész, T., & Holton, J. L. (2003) · Movement Disorders · doi:10.1002/mds.10558 · Cited by 18

The effect of age and the H1c MAPT haplotype on MAPT expression in human brain

Hayesmoore, J. B. G., Bray, N. J., Cross, W. C. H., Owen, M. J., O’Donovan, M. C., & Morris, H. R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.017 · Cited by 19

From 1997 to 2007: A decade journey through the H1 haplotype on 17q21 chromosome

Kalinderi, K., Fidani, L., & Bostantjopoulou, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.03.001 · Cited by 19

Novel tau filament fold in corticobasal degeneration, a four-repeat tauopathyPreprint

Zhang, W., Tarutani, A., Newell, K. L., Murzin, A. G., Matsubara, T., Falcon, B., Vidal, R., Garringer, H. J., Shi, Y., Ikeuchi, T., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/811703 · Cited by 19

Differential vulnerability of the dentate gyrus to tauopathies in dementias

Kawles, A., Minogue, G., Zouridakis, A., Keszycki, R. M., Gill, N. P., Nassif, C., Coventry, C., Zhang, H., Rogalski, E. J., Flanagan, M. E., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01485-7 · Cited by 18

Neurodegenerative Diseases

Cochran, E. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0949-0.00006-6 · Cited by 19

Alzheimer's disease and related dementias

Hardy, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.003 · Cited by 18

Mutation Screening of the MAPT and STH Genes in Polish Patients with Clinically Diagnosed Frontotemporal Dementia

Żekanowski, C., Pepłońska, B., Styczyńska, M., Gustaw, K. A., Kuźnicki, J., & Barcikowska, M. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000070999 · Cited by 18

Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases

Cervera‐Carles, L., Pagonabarraga, J., Pascual‐Sedano, B., Pástor, P., Campolongo, A., Fortea, J., Blesa, R., Alcolea, D. A., Morenas‐Rodríguez, E., Sala, I., et al. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32390 · Cited by 17

Tau levels do not influence human ALS or motor neuron degeneration in the SOD1 G93A mouse

Taes, I., Goris, A., Lemmens, R., van Es, M. A., van den Berg, L. H., Chiò, A., Traynor, B. J., Birve, A., Andersen, P. M., Slowik, A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e042f7 · Cited by 17

Biomarkers in frontotemporal lobar degeneration

Grossman, M. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833fd540 · Cited by 17

Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects

Alyenbaawi, H., Allison, W. T., & Mok, S. (2020) · Biomolecules · doi:10.3390/biom10111487 · Cited by 20

Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration

Ling, H. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.031 · Cited by 18

H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers

Canu, E., Boccardi, M., Ghidoni, R., Benussi, L., Testa, C., Pievani, M., Bonetti, M., Binetti, G. G., & Frisoni, G. B. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.185 · Cited by 17

The architecture of the tau haplotype block in different ethnicities

Fung, H., Evans, J. J., Evans, E. W., Duckworth, J., Pittman, A. M., de Silva, R., Myers, A., & Hardy, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.072 · Cited by 17

ATYPICAL PARKINSONIAN DISORDERS

Litvan, I. (2004) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293567.17705.8e · Cited by 17

Longitudinal Tracking of FTLD

Knopman, D. S., Boeve, B. F., Caselli, R. J., Graff‐Radford, N. R., Kramer, J. H., Mendez, M. F., & Miller, B. L. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815bf69d · Cited by 17

A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain

Green, E., Thaker, U., McDonagh, A. M., Iwatsubo, T., Lambert, J., Chartier‐Harlin, M., Harris, J. M., Pickering-Brown, S. M., Lendon, C. L., & Mann, D. M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00190-8 · Cited by 17

Pathomechanisms of cognitive impairment in progressive supranuclear palsy

Jellinger, K. A. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02613-w · Cited by 16

Frontotemporal Dementia

Kertesz, A. (2008) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e31818a8c66 · Cited by 18

The +347 C promoter allele up-regulates MAPT expression and is associated with Alzheimer's disease among the Chinese Han

Sun, W., & Jia, J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.067 · Cited by 16

Optimization of in vitro conditions to study the arachidonic acid induction of 4R isoforms of the microtubule-associated protein tau

Mutreja, Y., & Gamblin, T. C. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.007 · Cited by 17

VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome

Borroni, B., Bo, R. D., Goldwurm, S., Archetti, S., Bonvicini, C., Agosti, C., Bigni, B., Papetti, A., Ghezzi, S., Sacilotto, G., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091615 · Cited by 16

Therapeutic Potential of Small Interfering RNA for Central Nervous System Diseases

Lovett‐Racke, A. E., Cravens, P. D., Gocke, A. R., Racke, M. K., & Stüve, O. (2005) · Archives of Neurology · doi:10.1001/archneur.62.12.1810 · Cited by 16

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration

Koga, S., Metrick, M. A., Golbe, L. I., Santambrogio, A., Kim, M., Soto‐Beasley, A. I., Walton, R. L., Baker, M., Castro, C. H. F. D., Deture, M. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01584-z · Cited by 17

One decade ago, one decade ahead in progressive supranuclear palsy

Stamelou, M., Giagkou, N., & Höglinger, G. U. (2019) · Movement Disorders · doi:10.1002/mds.27788 · Cited by 14

No association of the SOD1 locus and disease susceptibility or phenotype in sporadic ALS

Broom, W. J., Parton, M. J., Vance, C. A., Russ, C., Andersen, P. M., Hansen, V. K., Leigh, P. N., Powell, J. F., Al‐Chalabi, A., & Shaw, C. E. (2004) · Neurology · doi:10.1212/01.wnl.0000147264.60349.eb · Cited by 15

Exome sequencing in familial corticobasal degeneration

Fekete, R., Bainbridge, M. N., Baizabal‐Carvallo, J. F., Rivera, A. L., Miller, B. B., Du, P., Kholodovych, V. V., Powell, S. Z.-E., & Ondo, W. G. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.06.016 · Cited by 14

Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome

Borroni, B., Goldwurm, S., Cerini, C., Cosseddu, M., Meucci, N., Mariani, C. B., Pezzoli, G., & Padovani, A. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03081.x · Cited by 14

Serotonin transporter and saitohin genes in risk of Alzheimer’s disease and frontotemporal lobar dementia: preliminary findings

Lorenzi, C., Marcone, A., Pirovano, A., Marino, E., Cordici, F., Cerami, C., Delmonte, D., Cappa, S. F., Bramanti, P., & Smeraldi, E. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0400-8 · Cited by 14

No evidence for association between taugene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease

Sánchez‐Juan, P., Bishop, M., Green, A. J. E., Giannattasio, C., Vásquez, A. A., Poleggi, A., Knight, R., & van Duijn, C. M. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-77 · Cited by 14

Pick Complex—Historical Introduction

Kertesz, A. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815bf65a · Cited by 14

Brain TDP‐43 pathology in corticobasal degeneration: Topographical correlation with neuronal loss

Sainouchi, M., Tada, M., Fitrah, Y. A., Hara, N., Tanaka, K., Idezuka, J., Aida, I., Nakajima, T., Miyashita, A., Akazawa, K., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12786 · Cited by 14

Frontotemporal Dementia

Clark, D. G. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001506 · Cited by 14

Tau haplotype influences cerebral perfusion pattern in frontotemporal lobar degeneration and related disorders

Borroni, B., Perani, D., Agosti, C., Anchisi, D., Paghera, B., Archetti, S., Alberici, A., Luca, M. D., & Padovani, A. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00955.x · Cited by 13

Diseases of movement and system degenerations

Ince, P. G., Clark, B., Holton, J. L., Révész, T., & Wharton, S. B. (2008) · CRC Press eBooks · doi:10.1201/b13319-14 · Cited by 13

Gene transfer therapy for neurodegenerative disorders

Feigin, A., & Eidelberg, D. (2007) · Movement Disorders · doi:10.1002/mds.21423 · Cited by 13

Visualization ofMAPT inversion on stretched chromosomes of tau-negative frontotemporal dementia patients

Gijselinck, I., Bogaerts, V., Rademakers, R., van der Zee, J., Broeckhoven, C. V., & Cruts, M. (2006) · Human Mutation · doi:10.1002/humu.20391 · Cited by 13

Free Radicals and Oxidative Stress in Neurodegenerative Disorders

Nigam, D. (2014) · Springer eBooks · doi:10.1007/978-81-322-2035-0_11 · Cited by 13

Phenotypic Variation of Autosomal-Dominant Corticobasal Degeneration

Jung, H. H., Bremer, J., Streffer, J. R., Virdee, K., Spillantini, M. G., Crowther, R. A., Brugger, P., Broeckhoven, C. V., Aguzzi, A., & Tolnay, M. (2012) · European Neurology · doi:10.1159/000334731 · Cited by 11

Frontotemporal lobar degeneration: clinical and pathologic overview.

Rabinovici, G., Rascovsky, K., & Miller, B. (2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)01233-x · Cited by 11

Les aspects génétiques de la maladie d’Alzheimer (Revue)

Kadmiri, N. E., Hamzi, K., Moutawakil, B. E., Slassi, I., & Nadifi, S. (2013) · Pathologie Biologie · doi:10.1016/j.patbio.2013.04.001 · Cited by 20

Diagnosis and Management of Progressive Corticobasal Syndrome

Nouh, C. D., & Younes, K. (2024) · Current Treatment Options in Neurology · doi:10.1007/s11940-024-00797-4 · Cited by 11

Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations

Voicu, V. A., Tătaru, C. P., Toader, C., Covache-Busuioc, R.-A., Glavan, L.-A., Bratu, B.-G., Costin, H. P., Corlatescu, A.-D., & Ciurea, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241613006 · Cited by 12

Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?

del Giudice, K. P., Cosgaya, M., Zaro, I., Ravasi, V., Santacruz, P., Painous, C., Fernández, M., Cámara, A., & Compta, Y. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106080 · Cited by 10

Progressive supranuclear palsy

Golbe, L. I. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.045 · Cited by 10

H1/H1 genotype influences symptom severity in corticobasal syndrome

Litvan, I., Chism, A., Litvan, J., Cambon, A. C., & Hutton, M. L. (2010) · Movement Disorders · doi:10.1002/mds.22804 · Cited by 9

Advances in the pathogenesis of Alzheimer’s disease: A re-evaluation of the Amyloid cascade hypothesis

Chukwu, L. C., Ekenjoku, J. A., Ohadoma, S. C., Olisa, C. L., Okam, P. C., Okany, C. C., Ramalam, M. A., & Innocent, O. C. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.17.2.20200335 · Cited by 10

Brain tau isoform mRNA and protein correlation in PSP brain

Luk, C. Y., Vandrovcová, J., Malzer, E., Lees, A. J., & de Silva, R. (2010) · Translational Neuroscience · doi:10.2478/v10134-010-0009-8 · Cited by 9

Genética de las enfermedades neurodegenerativas más prevalentes

Lladó, A., Gaig, C., & Molinuevo, J. L. (2006) · Medicina Clínica · doi:10.1157/13087844 · Cited by 9

Parkinsonian Syndromes

Gilman, S. (2006) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2006.06.007 · Cited by 9

The Clinical Overlap between the Corticobasal Degeneration Syndrome and Other Diseases of the Frontotemporal Spectrum: Three Case Reports

Raggi, A., Marcone, A., Iannaccone, S., Ginex, V., Perani, D., & Cappa, S. F. (2007) · Behavioural Neurology · doi:10.1155/2007/218189 · Cited by 9

No evidence for tau duplications in frontal temporal dementia families showing genetic linkage to the tau locus in which tau mutations have not been found

Johnson, J. O., Ostojic, J., Lannfelt, L., Glaser, A., Basun, H., Rogaeva, E. A., Kawarai, T., Bruni, A. C., George‐Hyslop, P. S., Goate, A., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.03.070 · Cited by 9

Frontotemporal dementia

Perry, D. C., & Rosen, H. J. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch5 · Cited by 9

Epidemiological aspects of frontotemporal dementia

Swieten, J. C. V., & Rosso, S. M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01232-8 · Cited by 7

A proteomic study identifies different levels of light chain ferritin in corticobasal degeneration and progressive supranuclear palsy

Ebrahim, A. S., Kulathingal, J., Murray, M. E., Casey-Castanedes, M., Dickson, D. W., Yen, S.-H. C., & Sevlever, D. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0888-x · Cited by 8

Neuropathology of dementia

Kim, E.-J., Vatsavayai, S., & Seeley, W. W. (2016) · The Behavioral Neurology of Dementia · doi:10.1017/9781139924771.008 · Cited by 7

Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders

Tang, F., Wei, J., Wong, M.-L., & Lei, P. (2025) · Genomic psychiatry : · doi:10.61373/gp025i.0122 · Cited by 7

Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations

Eusébio, A., Koric, L., Félician, O., Guedj, E., Ceccaldi, M. P., & Azulay, J. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.07.009 · Cited by 7

Parkinsonian Dementias

Possin, K., & Kaufer, D. (2010) · Continuum · doi:10.1212/01.con.0000368212.86835.a8 · Cited by 4

Procerus Sign in Corticobasal Degeneration.

Warabi, Y., Nagao, M., Bandoh, M., Kanda, T., & Hirai, S. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.1217 · Cited by 7

Association of microtubule associated protein tau/Saitohin (MAPT/STH) MAPT_238bp/STH Q7R polymorphisms and Parkinson’s disease: A meta-analysis

Lu, S., Gong, F., Feng, F., Hu, C., Qian, Z., Wu, Y., Yang, H., & Sun, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.013 · Cited by 7

Tangle Diseases and the Tau Haplotypes

Hardy, J., Pittman, A. M., Myers, A., Fung, H., de Silva, R., & Duckworth, J. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201853.54493.d8 · Cited by 7

Inherited movement disorders

Sharma, N., & Standaert, D. G. (2002) · Neurologic Clinics · doi:10.1016/s0733-8619(01)00014-7 · Cited by 7

Molecular genetics of early-onset Alzheimer's disease and frontotemporal lobar degeneration

Krüger, J. (2010) · Cited by 7

IgLON5-IgG: Innocent Bystander or Perpetrator?

Andersen, J., Jeffrey, B., Varikatt, W., Rodriguez, M., Lin, M., & Brown, D. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147956 · Cited by 6

Neuropathology of dementia

Macedo, M. N., Kim, E., & Seeley, W. W. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.011 · Cited by 6

A Patient with Corticobasal Syndrome and Progressive Non-Fluent Aphasia (CBS-PNFA), with Variants in ATP7B, SETX, SORL1, and FOXP1 Genes

Gawęda-Walerych, K., Sitek, E. J., Borczyk, M., Narożańska, E., Brockhuis, B., Korostyński, M., Schinwelski, M. J., Siemiński, M., Sławek, J. W., & Żekanowski, C. (2022) · Genes · doi:10.3390/genes13122361 · Cited by 7

Procerus sign: Mechanism, clinical usefulness, and controversies

Bhattacharjee, S. (2018) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_408_17 · Cited by 6

The Genetic Background of the Immunological and Inflammatory Aspects of Progressive Supranuclear Palsy

Alster, P., & Madetko‐Alster, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093927 · Cited by 5

Progressive Supranuclear Palsy

Morris, H. R. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00021-0 · Cited by 5

Clinical and Pathologic Evidence of Corticobasal Degeneration and Progressive Supranuclear Palsy in Familial Tauopathy

Tuite, P., Clark, H. B., Bergeron, C., Bower, M., George‐Hyslop, P. S., Mateva, V., Anderson, J. H., & Knopman, D. S. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.1453 · Cited by 29

Untitled work

Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3

Pathologically confirmed corticobasal degeneration shares the same tau haplotype association as progressive supranuclear palsy

Houlden, H., Baker, M., Bhatia, K. P., Hutton, M. L., Wood, N., & Corticobasal Degeneration Collabor (2000) · UCL Discovery (University College London) · Cited by 1

Progressive supranuclear palsy and corticobasal degeneration: Lumping versus splitting

Scaravilli, T., TOLOSA, E. S., & Ferrer, I. (2005) · Movement Disorders · doi:10.1002/mds.20536 · Cited by 49

Chapter 6 Progressive Supranuclear Palsy and Corticobasal Degeneration

Lees, A. J. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70057-7 · Cited by 2